Sign in
Back
Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?
Journal article   Open access  Peer reviewed

Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Premal Patel, Mikkel Fode, Tom Lue and Ranjith Ramasamy
European urology focus, Vol.5(4), pp.526-528
2019-07
DOI: https://doi.org/10.1016/j.euf.2019.02.004
PMID: 30777724

Abstract

Some trials have shown an overall benefit of low-intensity extracorporeal shockwave therapy (LI-ESWT) for erectile dysfunction, while others have been unable to find differences between LI-ESWT and sham treatment. In the absence of definitive evidence, patients should only be offered LI-ESWT in an investigational setting or on an off-label basis with a thorough understanding of the risks and benefits.
url
https://doi.org/10.1016/j.euf.2019.02.004View
Published (Version of record) Open

Metrics

25 Record Views
6 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.142 Urology
1.142.484 Erectile Dysfunction
Web Of Science research areas
Urology & Nephrology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Details